Literature DB >> 35099249

Methamphetamine, neurotransmitters and neurodevelopment.

B Čechová1, R Šlamberová.   

Abstract

Methamphetamine (MA), as massively abused psychoactive stimulant, has been associated with many neurological diseases. It has various potent and neurotoxic properties. There are many mechanisms of action that contribute to its neurotoxic and degenerative effects, including excessive neurotransmitter (NEU) release, blockage of NEU uptake transporters, degeneration of NEU receptors, process of oxidative stress etc. MA intoxication is caused by blood-brain barrier disruption resulted from MA-induced oxidation stress. In our laboratory we constantly work on animal research of MA. Our current interest is to investigate processes of MA-induced alteration in neurotransmission, especially during development of laboratory rat. This review will describe current understanding in role of NEUs, which are affected by MA-induced neurotoxicity caused by altering the action of NEUs in the central nervous system (CNS). It also briefly brings information about NEUs development in critical periods of development.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 35099249      PMCID: PMC8884400          DOI: 10.33549/physiolres.934821

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  76 in total

Review 1.  Role of altered brain serotonin mechanisms in autism.

Authors:  D C Chugani
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

2.  Early prenatal ontogeny of central monoamine neurons in the rat: fluorescence histochemical observations.

Authors:  L Olson; A Seiger
Journal:  Z Anat Entwicklungsgesch       Date:  1972

3.  Key role of 5-HT1B receptors in the regulation of paradoxical sleep as evidenced in 5-HT1B knock-out mice.

Authors:  B Boutrel; B Franc; R Hen; M Hamon; J Adrien
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

Review 4.  Overview of Monoamine Transporters.

Authors:  Shaili Aggarwal; Ole V Mortensen
Journal:  Curr Protoc Pharmacol       Date:  2017-12-20

5.  Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic.

Authors:  Q Y Zhou; R D Palmiter
Journal:  Cell       Date:  1995-12-29       Impact factor: 41.582

Review 6.  Prokaryotic ubiquitin-like protein (Pup), proteasomes and pathogenesis.

Authors:  K Heran Darwin
Journal:  Nat Rev Microbiol       Date:  2009-06-01       Impact factor: 60.633

7.  Global changes to the ubiquitin system in Huntington's disease.

Authors:  Eric J Bennett; Thomas A Shaler; Ben Woodman; Kwon-Yul Ryu; Tatiana S Zaitseva; Christopher H Becker; Gillian P Bates; Howard Schulman; Ron R Kopito
Journal:  Nature       Date:  2007-08-09       Impact factor: 49.962

8.  Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine.

Authors:  R Kuczenski; D S Segal; A K Cho; W Melega
Journal:  J Neurosci       Date:  1995-02       Impact factor: 6.167

9.  Cellular and molecular mechanisms of drug dependence: An overview and update.

Authors:  Swapnil Gupta; Parmananda Kulhara
Journal:  Indian J Psychiatry       Date:  2007-04       Impact factor: 1.759

10.  Dopaminergic dynamics underlying sex-specific cocaine reward.

Authors:  Erin S Calipari; Barbara Juarez; Carole Morel; Deena M Walker; Michael E Cahill; Efrain Ribeiro; Ciorana Roman-Ortiz; Charu Ramakrishnan; Karl Deisseroth; Ming-Hu Han; Eric J Nestler
Journal:  Nat Commun       Date:  2017-01-10       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.